Clinical trial

Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's Disease

NCT02982512

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Dexmedetomidine Normalized identity: dexmedetomidineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's Disease

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-05-01

PhasePHASE4

Conditions

Dexmedetomidineunresolved

Deep Brain Stimulationunresolved

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

DexmedetomidineDRUG · verified · RxNorm: dexmedetomidine

Sponsors & collaborators

Clinica Universidad de Navarra, Universidad de Navarralead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02982512 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.